Last reviewed · How we verify

Bupivacaine(B)

Huazhong University of Science and Technology · FDA-approved active Small molecule

Bupivacaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and propagation of action potentials.

Bupivacaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and propagation of action potentials. Used for Local anesthesia for infiltration, nerve block, epidural, and spinal anesthesia, Pain management in surgical and dental procedures.

At a glance

Generic nameBupivacaine(B)
SponsorHuazhong University of Science and Technology
Drug classLocal anesthetic (amide)
TargetVoltage-gated sodium channels
ModalitySmall molecule
Therapeutic areaAnesthesia
PhaseFDA-approved

Mechanism of action

Bupivacaine reversibly binds to and inactivates voltage-gated sodium channels on the inner surface of nerve cell membranes, thereby preventing depolarization and conduction of nerve impulses. This results in local anesthesia of the area where it is administered. It is a long-acting amide-type local anesthetic with a relatively slow onset but prolonged duration of action compared to other local anesthetics.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results